Chronic social isolation-unpredictable stress induces early-onset cognitive deficits and exacerbates Aβ accumulation in the 5xFAD mouse model of Alzheimer's disease
- PMID: 40467855
- DOI: 10.1038/s41380-025-03067-0
Chronic social isolation-unpredictable stress induces early-onset cognitive deficits and exacerbates Aβ accumulation in the 5xFAD mouse model of Alzheimer's disease
Abstract
Aging and genetic predisposition are the primary risk factors for Alzheimer's disease (AD), while chronic stress represents a modifiable risk factor that can accelerate aging and drive AD progression. However, the complex interplay between aging, chronic stress and genetic underpinnings in AD pathogenesis remains poorly understood. Notably, cognitive phenotyping in AD mouse models has yielded inconsistent results. In this study, we characterized the age-dependent trajectory of phenotypes in 5xFAD mice on a congenic C57BL/6 J background. These mice harbor five familial AD (FAD)-related mutations in the amyloid precursor protein (APP) and presenilin 1 (PSEN1) genes. Aβ plaque deposition was detected in specific brain regions by 4 months of age, but cognitive performance remained intact at this stage. However, by 8-9 months, these mice developed impairments in spatial working memory, novel object recognition memory, and social recognition memory. By 11 months, they also showed metabolic alterations, including lower body weight, higher energy expenditure and increased locomotor activity. Furthermore, after 10 days of chronic social isolation-unpredictable stress, 4-month-old 5xFAD mice exhibited cognitive deficits, accompanied by increased Aβ accumulation in the medial prefrontal cortex, hippocampus, and entorhinal cortex. In contrast, age- and sex-matched wild-type littermate controls subjected to the same stress paradigm showed no significant cognitive changes. These observations suggest that Aβ deposition increases stress vulnerability in 5xFAD mice. We conclude that the phenotypic expression of AD-related gene mutations, including pathological changes and cognitive decline, progresses with age and can be induced by chronic psychological stress, underscoring the interactive effects of stress, aging, and genetic vulnerability on disease onset and severity.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethics approval: All animal procedures were approved by the Institutional Animal Care and Use Committee of Augusta University (Animal Use Protocol #2017-0868) and conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals.
Similar articles
-
Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.Eur J Neurosci. 2010 Jan;31(1):110-8. doi: 10.1111/j.1460-9568.2009.07031.x. Epub 2009 Dec 21. Eur J Neurosci. 2010. PMID: 20092558 Free PMC article.
-
Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.BMC Neurosci. 2019 Mar 20;20(1):13. doi: 10.1186/s12868-019-0496-6. BMC Neurosci. 2019. PMID: 30894120 Free PMC article.
-
BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.FASEB J. 2020 Jan;34(1):1412-1429. doi: 10.1096/fj.201901984R. Epub 2019 Dec 1. FASEB J. 2020. PMID: 31914599
-
Intact olfactory memory in the 5xFAD mouse model of Alzheimer's disease from 3 to 15 months of age.Behav Brain Res. 2020 Sep 1;393:112731. doi: 10.1016/j.bbr.2020.112731. Epub 2020 Jun 6. Behav Brain Res. 2020. PMID: 32522622
-
Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.Int Rev Neurobiol. 2019;148:169-230. doi: 10.1016/bs.irn.2019.10.017. Epub 2019 Oct 23. Int Rev Neurobiol. 2019. PMID: 31733664 Free PMC article. Review.
References
-
- Alzheimer’s Association. 2024 Alzheimer’s disease facts and figures. Alzheimers Dement 2024;20:3708–821.
Grants and funding
- AG083841/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- AG062166/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- AG064895/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
- AG076235/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)
LinkOut - more resources
Full Text Sources
Molecular Biology Databases